- Home
- XERS vs DNUT Comparison
XERS vs DNUT Comparison
Compare XERS & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- DNUT
- Stock Information
- Founded
- XERS 2005
- DNUT 1937
- Country
- XERS United States
- DNUT United States
- Employees
- XERS N/A
- DNUT N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- DNUT Food Chains
- Sector
- XERS Health Care
- DNUT Consumer Staples
- Exchange
- XERS Nasdaq
- DNUT Nasdaq
- Market Cap
- XERS 628.7M
- DNUT 739.0M
- IPO Year
- XERS 2018
- DNUT 2021
- Fundamental
- Price
- XERS $5.01
- DNUT $2.73
- Analyst Decision
- XERS Strong Buy
- DNUT Buy
- Analyst Count
- XERS 6
- DNUT 8
- Target Price
- XERS $6.25
- DNUT $10.58
- AVG Volume (30 Days)
- XERS 2.2M
- DNUT 5.9M
- Earning Date
- XERS 05-08-2025
- DNUT 05-08-2025
- Dividend Yield
- XERS N/A
- DNUT 5.15%
- EPS Growth
- XERS N/A
- DNUT N/A
- EPS
- XERS N/A
- DNUT N/A
- Revenue
- XERS $222,551,000.00
- DNUT $1,597,883,000.00
- Revenue This Year
- XERS $31.75
- DNUT N/A
- Revenue Next Year
- XERS $21.09
- DNUT $9.87
- P/E Ratio
- XERS N/A
- DNUT N/A
- Revenue Growth
- XERS 29.88
- DNUT N/A
- 52 Week Low
- XERS $1.72
- DNUT $3.03
- 52 Week High
- XERS $6.07
- DNUT $13.25
- Technical
- Relative Strength Index (RSI)
- XERS 59.63
- DNUT 20.89
- Support Level
- XERS $4.26
- DNUT $4.17
- Resistance Level
- XERS $5.28
- DNUT $4.44
- Average True Range (ATR)
- XERS 0.28
- DNUT 0.27
- MACD
- XERS 0.09
- DNUT -0.06
- Stochastic Oscillator
- XERS 78.91
- DNUT 7.50
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About DNUT Krispy Kreme Inc.
Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.